US Study Links Youth Depression to Higher Prescription Drug Misuse

A study published in JAMA Network Open, utilizing data from the National Survey on Drug Use and Health for 2023 and 2024, has identified a significant link between depression and the misuse of prescription medications among young people in the United States.

Researchers analyzed a sample of over 50,000 individuals aged 12 to 25. The findings indicate that youths who experienced a major depressive episode in the previous year were twice as likely to misuse prescription drugs and four times as likely to meet the criteria for a substance use disorder compared to their peers without depression.

The study examined several drug classes, including opioid analgesics, tranquilizers (such as benzodiazepines), stimulants, and sedatives. Notably, those misusing opioids and tranquilizers frequently cited the management of emotions and psychological distress as a primary motivation for their actions.

Experts suggest that these results highlight a critical need to integrate mental health assistance with the identification and treatment of problematic substance use behaviors in adolescent and young adult populations.